“PROM2 decreases cisplatin sensitivity in non-small cell lung cancer and is regulated by CTCF” (2023) Radiology and Oncology, 57(3), pp. 325–336. Available at: https://radioloncol.com/index.php/ro/article/view/4013 (Accessed: 24 September 2026).